Search Results

There are 3690 results for: content related to: Oncogenic roles of PRL -3 in FLT 3- ITD induced acute myeloid leukaemia

  1. You have full text access to this OnlineOpen article
    Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD–negative acute myeloid leukemia

    Cancer

    Volume 120, Issue 14, 15 July 2014, Pages: 2130–2141, Shuang Qu, Bin Liu, Xiaoling Guo, Hongshun Shi, Meifeng Zhou, Li Li, Shulan Yang, Xiuzhen Tong and Haihe Wang

    Version of Record online : 15 APR 2014, DOI: 10.1002/cncr.28668

  2. You have free access to this content
    Constitutively activated FLT3 phosphorylates BAD partially through Pim-1

    British Journal of Haematology

    Volume 134, Issue 5, September 2006, Pages: 500–509, Kyu-Tae Kim, Mark Levis and Donald Small

    Version of Record online : 26 JUL 2006, DOI: 10.1111/j.1365-2141.2006.06225.x

  3. You have free access to this content
    ITD- and FL-induced FLT3 signal transduction leads to increased C/EBPβ-LIP expression and LIP/LAP ratio by different signalling modules

    British Journal of Haematology

    Volume 148, Issue 5, March 2010, Pages: 777–790, Sandra C. Haas, René Huber, Romina Gutsch, Judith D. Kandemir, Christian Cappello, Jürgen Krauter, Justus Duyster, Arnold Ganser and Korbinian Brand

    Version of Record online : 1 DEC 2009, DOI: 10.1111/j.1365-2141.2009.08012.x

  4. You have free access to this content
    Ponatinib may overcome resistance of FLT3-ITD harbouring additional point mutations, notably the previously refractory F691I mutation

    British Journal of Haematology

    Volume 157, Issue 4, May 2012, Pages: 483–492, Elisabeth Zirm, Bärbel Spies-Weisshart, Florian Heidel, Ulf Schnetzke, Frank-Dietmar Böhmer, Andreas Hochhaus, Thomas Fischer and Sebastian Scholl

    Version of Record online : 13 MAR 2012, DOI: 10.1111/j.1365-2141.2012.09085.x

  5. Preclinical and Phase I Results of Decitabine in Combination with Midostaurin (PKC412) for Newly Diagnosed Elderly or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 12, December 2013, Pages: 1341–1352, Casey B. Williams, Suman Kambhampati, Warren Fiskus, Jo Wick, Catherine Dutreix, Siddartha Ganguly, Omar Aljitawi, Ruben Reyes, Allan Fleming, Sunil Abhyankar, Kapil N. Bhalla and Joseph P. McGuirk

    Version of Record online : 24 JUN 2013, DOI: 10.1002/phar.1316

  6. You have free access to this content
    Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice

    British Journal of Haematology

    Volume 155, Issue 2, October 2011, Pages: 198–208, Amanda Nordigården, Jenny Zetterblad, Cecilia Trinks, Henrik Gréen, Pernilla Eliasson, Pia Druid, Kourosh Lotfi, Lars Rönnstrand, Thomas M. Walz and Jan-Ingvar Jönsson

    Version of Record online : 16 AUG 2011, DOI: 10.1111/j.1365-2141.2011.08819.x

  7. You have free access to this content
    The effect of cantharidins on leukemic stem cells

    International Journal of Cancer

    Volume 124, Issue 9, 1 May 2009, Pages: 2186–2199, David C. Dorn, Cynthia A. Kou, Kim J. Png and Malcolm A.S. Moore

    Version of Record online : 19 NOV 2008, DOI: 10.1002/ijc.24157

  8. You have free access to this content
    A role of Gab2 association in Flt3 ITD mediated Stat5 phosphorylation and cell survival

    British Journal of Haematology

    Volume 146, Issue 2, July 2009, Pages: 193–202, Kristina Masson, Tao Liu, Rasheed Khan, Jianmin Sun and Lars Rönnstrand

    Version of Record online : 12 MAY 2009, DOI: 10.1111/j.1365-2141.2009.07725.x

  9. You have full text access to this Open Access content
    Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling

    Molecular Oncology

    Volume 7, Issue 3, June 2013, Pages: 693–703, Julhash U. Kazi, Lars Rönnstrand

    Version of Record online : 19 MAR 2013, DOI: 10.1016/j.molonc.2013.02.020

  10. You have free access to this content
    The multi-kinase inhibitor TG02 overcomes signalling activation by survival factors to deplete MCL1 and XIAP and induce cell death in primary acute myeloid leukaemia cells

    British Journal of Haematology

    Volume 159, Issue 2, October 2012, Pages: 191–203, Monica Pallis, Amina Abdul-Aziz, Francis Burrows, Claire Seedhouse, Martin Grundy and Nigel Russell

    Version of Record online : 30 AUG 2012, DOI: 10.1111/bjh.12018

  11. You have free access to this content
    Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism

    International Journal of Cancer

    Volume 131, Issue 11, 1 December 2012, Pages: 2693–2703, Kevin R. Kelly, Steffan T. Nawrocki, Claudia M. Espitia, Mengkun Zhang, Johnny J. Yang, Swaminathan Padmanabhan, Jeffrey Ecsedy, Francis J. Giles and Jennifer S. Carew

    Version of Record online : 28 JUN 2012, DOI: 10.1002/ijc.27579

  12. You have free access to this content
    VEGF/KDR loop is a target of AG1296 in acute myeloid leukaemia showing FLT3-internal tandem duplications

    British Journal of Haematology

    Volume 145, Issue 6, June 2009, Pages: 836–838, Luis Arístides Torres, Nuria Barbarroja, Gabriel Dorado, Francisco Velasco and Chary López-Pedrera

    Version of Record online : 8 APR 2009, DOI: 10.1111/j.1365-2141.2009.07673.x

  13. You have free access to this content
    Flt3 mutations and leukaemia

    British Journal of Haematology

    Volume 122, Issue 4, August 2003, Pages: 523–538, Panagiotis D. Kottaridis, Rosemary E. Gale and David C. Linch

    Version of Record online : 5 AUG 2003, DOI: 10.1046/j.1365-2141.2003.04500.x

  14. Effect of GABA on the processing of interaural time differences in nucleus laminaris neurons in the chick

    European Journal of Neuroscience

    Volume 10, Issue 11, November 1998, Pages: 3438–3450, Susanne Brückner and Richard L. Hyson

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1460-9568.1998.00353.x

  15. Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the pediatric preclinical testing program

    Pediatric Blood & Cancer

    Volume 60, Issue 7, July 2013, Pages: E42–E45, Richard B. Lock, Hernan Carol, John M. Maris, Min H. Kang, C. Patrick Reynolds, E. Anders Kolb, Richard Gorlick, Stephen T. Keir, Catherine A. Billups, Raushan T. Kurmasheva, Peter J. Houghton and Malcolm A. Smith

    Version of Record online : 9 JAN 2013, DOI: 10.1002/pbc.24451

  16. You have free access to this content
    FLT3/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem/progenitor cells

    British Journal of Haematology

    Volume 137, Issue 1, April 2007, Pages: 64–75, Li Li, Obdulio Piloto, Kyu-Tae Kim, Zhaohui Ye, Ho Bao Nguyen, Xiaobing Yu, Mark Levis, Linzhao Cheng and Donald Small

    Version of Record online : 12 MAR 2007, DOI: 10.1111/j.1365-2141.2007.06525.x

  17. The organization of frequency and binaural cues in the gerbil inferior colliculus

    Journal of Comparative Neurology

    Volume 525, Issue 9, June 15, 2017, Pages: 2050–2074, Gilberto David Graña, Kendall A. Hutson, Alexandra Badea, Andrew Pappa, William Scott and Douglas C. Fitzpatrick

    Version of Record online : 10 MAR 2017, DOI: 10.1002/cne.24155

  18. You have free access to this content
    FMS-Like Tyrosine Kinase 3 in Normal Hematopoiesis and Acute Myeloid Leukemia

    STEM CELLS

    Volume 24, Issue 5, May 2006, Pages: 1174–1184, Bertrand W. Parcells, Alan K. Ikeda, Tiffany Simms-Waldrip, Theodore B. Moore and Kathleen M. Sakamoto

    Version of Record online : 12 JAN 2006, DOI: 10.1634/stemcells.2005-0519

  19. You have free access to this content
    Molecular mechanisms of the PRL phosphatases

    The FEBS Journal

    Volume 280, Issue 2, January 2013, Pages: 505–524, Pablo Rios, Xun Li and Maja Köhn

    Version of Record online : 10 APR 2012, DOI: 10.1111/j.1742-4658.2012.08565.x

  20. SIOP 2016 Scientific Programme+Index

    Pediatric Blood & Cancer

    Volume 63, Issue S3, November 2016, Pages: S5–S321,

    Version of Record online : 27 SEP 2016, DOI: 10.1002/pbc.26233